Menu Close

Articles on Dementia

Displaying 1 - 20 of 296 articles

Inflammatory cells surrounding amyloid plaque and activation of astrocytes, critical in maintaining the brain health. Curtin Health Innovation Research Institute

What allegations of Alzheimer’s research fraud mean for patients

Not all Alzheimer’s research has been compromised by allegations of scientific fraud. But we should interrogate whether the governing bodies of research and drug approvals are truly effective.
Communities that are underrepresented in research may also be at increased risk for dementia, or tend to experience dementia differently, often with poorer quality of care, later diagnoses and at possibly higher rates than the general population. (Shutterstock)

Research and patient services need to reflect that Canadians from diverse communities are living with dementia

Much dementia research does not reflect ethnically diverse communities. Studies used to make policy, clinical and investment decisions in dementia should reflect the diverse Canadian population.
An illustration of amyloid plaques within the human brain, characteristic features of Alzheimer’s. By 2060, approximately 14 million Americans are expected to have the disease. Kateryna Kon/Science Photo Library via Getty Images

The FDA approved a new drug to treat Alzheimer’s, but Medicare won’t always pay for it – a doctor explains what researchers know about Biogen’s Aduhelm

Although Medicare has agreed to pay for Aduhelm, its coverage comes with restrictions.
As the population of American Indian and Alaska Native adults ages, the risk for Alzheimer’s disease and other dementias – along with various chronic conditions – goes up. grandriver/E+ via Getty Images

Much of the cost of dementia care in aging Native American adults is due to hospitalization

A clearer understanding of the true treatment costs of dementia for American Indian and Alaska Native adults could help health services better meet the needs of the populations they serve.

Top contributors

More